The U.S. Food and Drug Administration today approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
Bajan ataques cardíacos y derrames en diabéticos
NUEVA YORK (AP) — En medio de la epidemia de diabetes, se produce un destello de buenas noticias: han disminuido los ataques cardíacos, los derrames cerebrales y otras complicaciones que provoca el mal.
Delirium severity score; obesity and diabetes; shock therapy for chronic calcific shoulder tendinitis – Annals of Internal Medicine
1. New delirium severity score helps to predict outcomes for hospitalized patientsA new delirium severity score proves accurate for predicting important clinical outcomes in hospitalized…
Mammograms less likely to be given to women with diabetes
Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative…
La Sociedad Española de Diabetes premia a La Candelaria por un proyecto de telemedicina
La Sociedad Española de Diabetes ha concedido al servicio de Endocrinología del Hospital Universitario Ntra. Sra. de Candelaria, adscrito a la Consejería de Sanidad del Gobierno de Canarias, el II Premio Best Practices in Diabetes Mellitus (BPDM) en el marco del XXV Congreso Nacional, celebrado en Pamplona los días 4 y 5 de abril.
NAFLD is likely an independent cardiovascular risk factor
Two new studies presented at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the…
Chromium supplementation not effective in lowering fasting glucose in diabetic and non-diabetic populations
Approximately 26 percent of the U.S. population has impaired fasting glucose, which is a predisposition for developing type 2 diabetes, and chromium supplementation has been suggested as a method…
¿Cómo puede ahorrar 8.000 millones la sanidad?
Cuatro grupos de enfermedades, cáncer, diabetes, enfermedades cardiovasculares y respiratorias, gastan el 75% de los recursos sanitarios en España. Leer
Translating Innovations in Diabetes Drug Development, 17-19 November 2014, London
Translating Innovations in Diabetes Drug Development is being held on the 17-19 November 2014 in London, United KingdomThe global diabetes market is projected to double from $ 32bn to $ 64bn…
Proteomics International biomarker study moves closer to a CDx test for diabetic kidney disease
Drug discovery company Proteomics International has completed an important milestone towards the development of a companion diagnostic (CDx) test with the validation of several of its protein…